Evidence map›Paper›PMID 42450147›Full record

ReviewInternational journal of molecular sciences2026

Multidimensional Classification of Insulin Resistance (MCIR) Focused on Therapeutic Targets and Interventions-A Comprehensive Review.

Dominik Nowakowski, Adrianna Zańko, Michał Pawłowski, Robert Milewski

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dominik NowakowskiDepartment of Biostatistics and Medical Informatics, Medical University of Bialystok, 15-295 Bialystok, Poland.ORCID 0000-0002-3515-4320
Adrianna ZańkoDepartment of Biostatistics and Medical Informatics, Medical University of Bialystok, 15-295 Bialystok, Poland.ORCID 0000-0002-4429-5037
Michał PawłowskiDepartment of Biostatistics and Medical Informatics, Medical University of Bialystok, 15-295 Bialystok, Poland.ORCID 0000-0003-0046-4633
Robert MilewskiDepartment of Biostatistics and Medical Informatics, Medical University of Bialystok, 15-295 Bialystok, Poland.ORCID 0000-0001-6241-8283

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin resistance (IR) is a common medical condition that plays a crucial role in the development of numerous diseases. Even though its overall mechanism is fairly simple and involves an insufficient response of tissues to insulin signaling resulting in increased hepatic glucose production, the condition's presentation and etiology are complex enough to warrant a broad review and re-classification. The aim of this study was to review the current scientific consensus concerning IR and its various manifestations and, based on the conclusions, create a comprehensive classification that would be focused on therapeutic aims and interventions catered to the various types of the condition. Using the available literature data, the existing approaches have been critically reviewed and collated into a novel classification of types of insulin resistance, named the Multidimensional Classification of Insulin Resistance (MCIR). As the review and the MCIR based on it provide useful insight into the biological phenomena involved in IR and clarify which therapeutic approaches and interventions are indicated for different types of IR, the results of this study should prove useful in clinical contexts. Further research into the condition is warranted because, despite its high prevalence, IR remains characterized by substantial empirical uncertainty, with various approaches and concepts often developing independently with insufficient overlap and consistency.

Indexed as

Insulin ResistanceAnimalsHumansInsulinSignal TransductionInsulinclassificationinsulin resistanceIR typesmetabolic disordersmolecular pathwaysphenotype

Identifiers

PMID42450147
PMCPMC13361987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.